Study with Greenwich  | Student Information  | About Us  | Research  | Contact Us

School of Science

Search

Search the university website

Intranet Login



Dionysis Douroumis


Douroumis

Dionysios Douroumis PhD
Senior Lecturer in Pharmaceutical Sciences

Office: Grenville 123B
Email: d.douroumis@gre.ac.uk
Tel:  +44 (0)20 8331 8440
Fax: +44 (0)20 8331 9805


Areas of Expertise
Pharmaceutical Nanomaterials, Liposome Research, Parenteral formulations (IV, SC, IM), Solid Lipid Nanoparticles (SLN), Tissue Engineering (scaffolds, composites), Biomaterials (Hydroxyapatite Composites), Mesoporous Silica Nanoparticles, Physicochemical Characterization of Drug Delivery Systems, Modified Release Formulations (wet granulation, direct compression, tablet coating), Taste masking of Bitter Drugs (Hot Melt Extrusion, Fluidize Bed).

Biography
Dr. Douroumis obtained his Diploma in Chemistry and PhD from the Department of Pharmacy (http://www.pharmacy.upatras.gr) at Patras Univeristy in Greece. He studied the development of electroanalytical techniques for in situ monitoring of drug release from liposomal formulations. He worked as a postdoc fellow (2004) in Friedrich – Schiller University of Jena, Dept. of Pharmacy (http://www.uni-jena.de/ls_fahr.html) with Prof. Alfred Fahr. He studied the development of parenteral formulations of antiepileptic drugs (post funded by Novartis Pharma, Basel, http://www.novartis.com). 
After the completion of this project he worked as a Team Leader (2005) again with Prof. Fahr for the development of nano – liposomal formulations and treatment of Rheumatoid Arthritis by applying Photodynamic Therapy (post funded by Biolitec Pharma GmbH, http://www.biolitec.de).

Later on he worked for Phoqus Pharmaceutical plc (http://www.phoqus.com) as a Senior Scientist (2005) at the Product Development Department. His main tasks ware the development of sustained/pulsatile release formulations, fast disintegrating dosage forms (FDDF) and taste masking of bitter drugs. He was also focused in the development of coated coronary stents (Cypher) using the novel electrostatic dry powder deposition technology (EDPDT).

Dr. Douroumis joined the School of Sciences of Greenwich University in November 2007. 

Course Participation

PHAR1049 Drug Design and Delivery
OMED0104 Pharmaceutical Analysis Lab Courses
PHAR0004 Pharmaceutical Formulation, Processing, Packaging and Control
PHAR1010 Pharmaceutics and Formulation

Further Information
Further information can be viewed by clicking on the following links: